指南与共识流行病学与生物统计

GRADE概念7:将指南推荐与可信基本药物清单相联系的问题与见解

GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists.
指南 / 共识 · J Clin Epidemiol · 2023-12-19

本文从GRADE工作组视角探讨指南与基本药物清单决策不协调的挑战及解决方案,通过多利益相关方参与、案例分析和调查反馈,提出早期规划对齐、共享参与、明确价格成本考量和共享标准等建议,以支持可信基本药物清单的制定。

要点

  • 指南与基本药物清单决策在WHO或国家层面并非总是协调一致。
  • 建议早期规划对齐、共享参与、明确价格成本考量并使用共享标准。
  • 结构化决策标准与指南推荐相联系可能促进健康公平和基本药物可及性。

核心结论

  • 本GRADE概念文章由指南和基本药物清单领域的关键利益相关方共同制定,识别了支持可信基本药物清单持续发展的关键概念问题和潜在解决方案。
  • 采用可与指南推荐相联系的结构化决策标准,有可能促进健康公平以及国家内部和国家之间基本药物可及性差距的改善。

研究设计与样本

  • 通过广泛利益相关方参与并评估包括WHO基本药物清单、南非国家基本药物清单和与WHO基本药物清单多发性硬化治疗申请相关的多发性硬化指南在内的真实应用案例,识别将基本药物清单与卫生指南联系的关键挑战。
  • 利用调查结果和利益相关方反馈,项目组迭代会议,起草挑战与潜在解决方案的概念框架。
  • 在2022年11月(约120人)和2023年5月(约100人)的GRADE工作组会议上向所有参会者展示结果摘要以征求反馈,然后最终确定框架。

主要发现

  • 优先处理了涉及基本药物清单与卫生指南联系的问题和见解/解决方案。
  • 建议的解决方案包括指南组与基本药物清单的早期规划对齐、考虑共享参与以加强联系、进一步明确价格/成本考量以及使用明确的共享标准来做出指南和基本药物清单决策。
  • 还提供了加强WHO基本药物清单与国家基本药物清单之间联系的建议,包括通过情境化方法。

关键数值与推荐

  • 原文未报告具体数值标准或推荐等级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Guidelines and essential medicine lists (EMLs) bear similarities and differences in the process that lead to decisions. Access to essential medicines is central to achieve universal health coverage. The World Health Organization (WHO) EML has guided prioritization of essential medicines globally for nearly 50 years, and national EMLs (NEMLs) exist in over 130 countries. Guideline and EML decisions, at WHO or national levels, are not always coordinated and aligned. We sought to explore challenges, and potential solutions, for decision-making to support trustworthy medicine selection for EMLs from a Grading of Recommendations, Assessment, Development and Evaluations (GRADE) Working Group perspective. We primarily focus on the WHO EML; however, our findings may be applicable to NEML decisions as well. STUDY DESIGN AND SETTING: We identified key challenges in connecting the EML to health guidelines by involving a broad group of stakeholders and assessing case studies including real applications to the WHO EML, South Africa NEML, and a multiple sclerosis guideline connected to a WHO EML application for multiple sclerosis treatments. To address challenges, we utilized the results of a survey and feedback from the stakeholders, and iteratively met as a project group. We drafted a conceptual framework of challenges and potential solutions. We presented a summary of the results for feedback to all attendees of the GRADE Working Group meetings in November 2022 (approximately 120 people) and in May 2023 (approximately 100 people) before finalizing the framework. RESULTS: We prioritized issues and insights/solutions that addressed the connections between the EML and health guidelines. Our suggested solutions include early planning alignment of guideline groups and EMLs, considering shared participation to strengthen linkage, further clarity on price/cost considerations, and using explicit shared criteria to make guideline and EML decisions. We also provide recommendations to strengthen the connection between WHO EML and NEMLs including through contextualization methods. CONCLUSION: This GRADE concept article, jointly developed by key stakeholders from the guidelines and EMLs field, identified key conceptual issues and potential solutions to support the continued advancement of trustworthy EMLs. Adopting structured decision criteria that can be linked to guideline recommendations bears the potential to advance health equity and gaps in availability of essential medicines within and between countries.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Piggott T, Moja L, Jenei K, et al. GRADE Concept 7: Issues and Insights Linking Guideline Recommendations to Trustworthy Essential Medicine Lists. J Clin Epidemiol. 2023. PMID: 38123105. doi:10.1016/j.jclinepi.2023.111241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。